Facing 1000s Of Lawsuits, Oxycontin Maker Purdue Weighs Bankruptcy Filing

    Updated: March 4, 2019 at 5:43 pm EST  See Comments

    Originally Published on This Site

    Tyler Durden
    March 4th, 2019
    Zero Hedge

    Read by 82 people

    This article was originally published by Tyler Durden at Zero Hedge

    Stamford-based Purdue Pharmaceuticals, which is facing thousands of lawsuits pertaining to its role in stoking the opioid epidemic that has been blamed for the surge in drug overdose deaths, is taking a page out of embattled Cali utility PG&E’s book.

    Like the embattled utility, the drug company, which is privately owned and controlled by the billionaire Sackler family, is considering filing chapter 11 bankruptcy to halt the mountain of lawsuits and negotiate its legal claims with plaintiffs.

    Here’s more from Reuters:

    The deliberations show how Purdue and its wealthy owners, the Sackler family, are under pressure to respond to mounting litigation accusing the pharmaceutical company of misleading doctors and patients about risks associated with prolonged use of its prescription opioids.

    Purdue denies the allegations, arguing that the U.S. Food and Drug Administration-approved labels for its opioids carried warnings about the risk of abuse and misuse associated with the drugs.

    Filing for Chapter 11 protection would halt the lawsuits and allow the drug maker to negotiate legal claims with plaintiffs under the supervision of a U.S. bankruptcy judge, the sources said.

    Purdue has been accused by dozens of states’ attorneys general of using deceptive marketing practices to push opioids like its Oxycontin while minimizing their addictive properties. The company told Reuters that it hasn’t made a final decision about the bankruptcy.

    A Purdue bankruptcy filing is not certain, the sources said. The Stamford, Connecticut, drug maker has not made any final decisions and could instead continue fighting the lawsuits, they said.

    “As a privately-held company, it has been Purdue Pharma’s longstanding policy not to comment on our financial or legal

    The remainder of this article is available in its entirety at SHTF Plan

    Share Your Thoughts

    A Quick Note…

    Already a subscriber? Login to remove advertisements. Not a subscriber? Join the Christian Journal and gain access to hundreds of presentations and exclusives that cover today's events and how they impact you, your life, and your soul. All while supporting independent Christian researchers trying to make a difference.